The Future of Brain-Computer Interfaces with Max Hodak (Y Combinator Startup Podcast)

Overview

In this episode of the Y Combinator Startup Podcast, Max Hodak—co-founder of Neuralink and founder of Science—joins the host for an in-depth conversation about the rapidly evolving field of brain-computer interfaces (BCIs). The discussion explores groundbreaking advances in restoring sight, the biological and technical challenges of interfacing with the brain, and the transformative implications of neural engineering on medicine and humanity’s future. With anecdotes from clinical trials and insights into learning, plasticity, and consciousness, Hodak paints a bold vision of where BCIs—and human health—are heading over the next decade.

Key Discussion Points & Insights

1. Breakthroughs in Restoring Sight via BCIs

• Clinical Trial Success

  • Science’s new retinal prosthesis, a 2x2mm silicon chip implanted under the retina, enables blind patients to regain vision by bypassing non-functional rods and cones (01:03).
  • More than 40 people have received the device, with a recent clinical trial across 17 European sites showing “a huge effect” (01:03).
  • Patients wear glasses equipped with a camera and laser projector that stimulates the chip, exciting the underlying retinal cells to restore visual input.

  "We can take a patient who's been unable to see faces for a decade and allow them to read every letter on an eye chart."
  — Max Hodak (13:15)

• How It Works

  • The device acts as a retinal stimulator, with image data transmitted to the brain by stimulating bipolar cells, identified as the key “API” for visual information (19:45-21:33).

2. Defining Brain-Computer Interfaces: Present and Future Applications

• Current Use Cases

  • BCIs are presently used to restore lost functionalities: vision, hearing, or movement for those with specific deficits (02:03).

• Structural Neural Engineering

  • Hodak outlines a future where BCIs move beyond restoration to enable new forms of cognitive processing, deeper understanding of the brain, and treatment of complex conditions like depression or addiction (02:03).

• Risk-Benefit Calculus in Adoption

  • Presently, serious brain surgeries for BCI implants are justified primarily for highly disabled patients, but as devices improve, wider adoption could follow, especially in aging populations (03:48-05:51).

3. Neuroplasticity and the Brain’s Adaptability

• Plasticity Across the Lifespan

  • Although critical periods exist in early development, the adult brain retains substantial plasticity, especially with feedback, allowing patients to adapt to new sensory inputs or learn to control neural signals (06:10-08:03).

  "Within a couple minutes, you can learn to control that neuron... The brain is very plastic under feedback."
  — Max Hodak (06:59)

• Rehabilitation Process

  • An intriguing finding: newly-implanted patients initially struggle to distinguish between real and phantom percepts. With rehabilitation, they learn to correctly attribute sensory experiences (09:49).

4. Qualia and the Subjective Experience of BCIs

• Nature of Restoration

  • The experience of restored vision (via the PRIMA implant) is “normal sight,” albeit in black and white with a limited field (09:49).

• Biohybrid and Brain-to-Brain Interfaces

  • The ultimate qualia of an ultra high-bandwidth, biohybrid interface is beyond our current imagination, but natural cases (like conjoined twins sharing thalamic connections) suggest profound new experiential territory (09:49-13:07).

  "There are these natural case studies that tell us that some really interesting things might be possible here. But it’s kind of tough to imagine what it would feel like."
  — Max Hodak (12:45)

5. Engineering Approaches vs. Drug Discovery in Medicine

• Reframing Medical Solutions

  • Hodak advocates for neural engineering as a more effective and direct solution to some forms of blindness than drug discovery, arguing BCI technology has delivered where expensive gene therapies have not (13:15-15:14).

• API of the Brain

  • The brain processes input/output via a “small number of cables”—the cranial and spinal nerves, which Hodak likens to well-defined APIs (18:00). Understanding this allows for more deliberate, systematic engineering of neural interfaces.

  "The brain is a computer... you can take that almost literally… it processes information… reality is whatever spikes are on the cranial and spinal nerves."
  — Max Hodak (18:00)

6. Biohybrid Neural Interfaces & Looking to Nature

• Living Neurons as Interfaces
  • Science’s biohybrid neural interfaces are seeded with hypoimmunogenic stem-cell-derived neurons. The aim is to grow a new nerve fiber bundle, inspired by the corpus callosum’s function of connecting brain hemispheres (29:04-32:15).
  • This could mean plug-and-play “ponytails” for super high-bandwidth brain-to-brain (or brain-to-computer) connections, reminiscent of Avatar's neural bonds (32:15).

7. Perfusion: A Third Frontier

• Heart-Lung Machine Technology

  • Science is also working on improved ECMO/perfusion devices, with the potential to dramatically improve survival and quality of life for patients awaiting organ transplants or needing long-term life support (39:54-44:24).

  "What if you could refine this to the point where you could check a kidney in like luggage on a United flight to the East Coast?"
  — Max Hodak (42:01)

8. Lessons in Innovation, Career, and the Path from Software to Hard Tech

• Origin Story

  • Hodak discusses his journey from programming and biomedical engineering to BCI entrepreneurship, initial exposure through science fiction, and his eventual work co-founding Neuralink with Elon Musk (24:53-46:07).

• Advice to Founders

  • He shares key career insights: combine clear ambition with agency, “sneak in” to the communities or labs you need (47:24–49:53), and go learn directly from those with proven ability before striking out on your own.

  "Often running a startup is an oral tradition... it’s an oral tradition that you get passed down from one of this handful of Silicon Valley cultures that can make a huge difference..."
  — Max Hodak (49:53)

Notable Quotes & Memorable Moments

• On the Future Impact:

  "I think it is very possible that the first people to live to a thousand are alive right now… It feels like we're firmly in the takeoff era now, like something new has happened on Earth."
  — Max Hodak (00:00, 51:26)

• On AI's Influence on Neuroscience:

  "We’re actually learning a lot from AI research, more than I think we thought we would learn from AI research. Ten years ago, we thought it would go the other way."
  — Max Hodak (18:00)

• On the Vision for BCIs:

  "A brain computer interface is equivalent to a brain to brain interface in many cases. This takes you to totally new territory."
  — Max Hodak (52:56)

• On Choosing Where to Start:

  "We started with [the retinal prosthesis] because it’s a huge unmet need and I think it’s the most valuable BCI product on the horizon that I thought was doable."
  — Max Hodak (13:15)

Important Timestamps & Segments

| Timestamp | Topic | | --------- | ----- | | 01:03 | Explanation of the PRIMA retinal prosthesis and clinical results | | 02:03 | What is a brain-computer interface? (definition & use cases) | | 06:10 | Neuroplasticity explained and examples | | 09:49 | Qualia, perception, and the experience of restored sight | | 13:15 | Comparing drug discovery to neural engineering | | 18:00 | Brain as a computational system; parallels with AI and software | | 19:45 | Discovering the retina’s ‘API’ and technology choices | | 24:53 | Hodak’s personal journey and inspiration | | 29:04 | Science’s biohybrid neural interface strategy | | 39:54 | Third Science project: Perfusion technology | | 44:43 | Hodak’s entry into Neuralink, working with Elon Musk | | 47:24 | Advice for founders: ambition, agency, learning from the best | | 51:26 | Predictions for 2035, longevity, and the dual revolution of AI + BCI |

Concluding Theme & Tone

Max Hodak and the host navigate the conversation with an optimistic, ambitious, and technically grounded tone. The dialogue emphasizes first principles thinking, bold bets on deep tech’s promise, and a vision for BCIs as a platform as far-reaching as pharmaceuticals. Hodak’s candor about both the limitations and frontiers of neural engineering will inspire entrepreneurs, scientists, and anyone interested in the future of human-machine collaboration.